Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 TrialChristopher L. Corless, Ronald P. DeMatteo, Robert G. Maki et al.|Journal of Clinical Oncology|2014Cited by 315
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal TumorRonald P. DeMatteo, Kouros Owzar, Karla V. Ballman et al.|Annals of Surgery|2013Cited by 174